Aterian, Inc. — Form 8-K Summary
Reporting context: Current report concerning events beginning September 23, 2026; filed September 29, 2026. This is not an earnings report and does not provide a quarterly or annual financial update.
Business, control and governance changes
- On September 25, David E. Lazar sold his interests in 706,100 Series AA preferred shares and 1,750,000 Series AAA preferred shares to multiple purchasers for an aggregate purchase price of $12 million. Immediately before the sale, the preferred shares converted into 241,861,970 common shares. The filing describes the purchase price as consideration for the sale; it does not identify it as proceeds to Aterian.
- After the transaction, Lazar held approximately 3.1% of outstanding common stock and may no longer be deemed to control the company. No purchaser held more than 9.99% of fully diluted common stock, and the purchasers reportedly had no agreement to act as a group. The company does not believe any person or group acquired control.
- Avraham Ben-Tzvi resigned from the Board and all Board committees, effective September 25. The filing says his resignation was not due to a disagreement with the company.
- William H. Crampton joined the Board and its Audit and Compensation Committees on September 25. He received a restricted stock award for 301,205 shares, vesting over three years subject to continued service.
Financial metrics and compensation
- The filing provides no revenue, profit, cash flow, margin, debt, liquidity, or operating-performance figures, and no comparable-period results.
- The Compensation Committee approved a $150,000 cash retention bonus for Lazar, who continued as CEO and Interim CFO through the filing of the company’s Form 10-Q for the quarter ended September 30, 2026. The bonus is payable in two $75,000 installments, with terms tied to continued service and specified termination circumstances.
- Aterian issued notice of a cash payment of approximately $0.9936 per contingent value right, expected to be distributed on or about October 2, 2026. The filing does not state the total payment amount.
Outlook, risks and notable items
No business guidance, financial outlook, or operating-risk discussion is provided. Key items are the change in control circumstances, the CEO/Interim CFO retention arrangement, the director equity award, and the announced CVR distribution.
Investor verification points
- Review the September 2026 securities purchase agreement and related disclosures to confirm purchaser allocations, transaction mechanics, and Lazar’s post-transaction ownership.
- Check the next 10-Q for financial results, liquidity, debt, and any updates on executive leadership.
- Review the retention letter for the complete bonus terms and confirm payment timing and any applicable conditions.
- Confirm the CVR distribution amount, payment date, and any remaining obligations under the CVR agreement.